Skip to main content

Table 2 Survival analysis

From: High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer

  

Disease-free survival

Overall survival

Univariate

Multivariate

Univariate

Multivariate

 

N (%)

p-value

p-value

HR

95% CI

p-value

p-value

HR

95% CI

Age at diagnosis

 < 60

92 (60.1)

0.184

-

  

0.001

0.483

1.381

0.559–3.411

 ≥ 60

61 (39.9)

        

DM/HTN

 None

105 (68.6)

0.455

-

  

0.115

_

  

 DM or HTN

48 (31.4)

        

Menopause

 no

55 (35.9)

0.437

-

  

0.231

_

  

 yes

98 (64.1)

        

BMI

 < 25

102 (66.7)

0.039

0.020

1.434

1.058–1.945

0.043

_

  

 ≥ 25

51 (33.3)

        

Histologic type

 Serous

100 (65.4)

< 0.001

-

  

0.029

_

  

 Endometroid

12 (7.8)

        

 Clear cell

14 (9.2)

        

 Mucinous

20 (13.1)

        

 Transitional cell

3 (1.9)

        

 MMMT

4 (2.6)

        

Cell type

 Serous

100 (65.4)

< 0.001

0.017

2.530

1.178–5.433

0.001

0.716

1.238

0.390–3.926

 Non-serous

53 (34.5)

        

First-line therapy

 PDS

135 (88.2)

< 0.001

0.049

2.017

1.000–4.068

0.001

0.967

1.023

0.342–3.052

 NAC

18 (11.8)

        

Surgical optimality

 Optimal

115 (75.2)

< 0.001

0.377

1.328

0.706–2.499

< 0.001

0.295

1.573

0.673–3.676

 Suboptimal

38 (24.8)

        

FIGO stage

 1

49 (32.0)

< 0.001

0.009

1.571

1.116–2.210

< 0.001

0.008

2.516

1.260–5.024

 2

8 (5.2)

        

 3

71 (46.4)

        

 4

25 (16.4)

        

Chemo-response

 Sensitive

112 (73.2)

< 0.001

0.012

2.007

1.160–3.475

< 0.001

0.027

2.786

1.121–6.923

 Resistant

20 (13.1)

        

 Unknown

21 (13.7)

        

tFMR

 < 2.22

79 (51.6)

0.328

-

  

0.303

_

  

 ≥ 2.22

74 (48.4)

        

vFMR

 < 0.83

86 (56.2)

0.035

0.989

0.995

0.547–1.812

0.002

0.014

3.302

1.269–8.594

 ≥ 0.83

67 (42.8)

        

SMI

 < 38.7

51 (33.3)

0.583

   

0.051

_

  

 ≥ 38.7

102 (66.7)

        
  1. DM/HTN Diabetes/hypertension, BMI Body mass index, PDS Primary debulking surgery, NAC Neoadjuvant chemotherapy, FMR Fat-to-muscle ratio, SMI Skeletal muscle index